Indaptus Therapeutics, Inc (INDP) insider trading
Every open-market stock purchase and sale by Indaptus Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $0 over the last 12 months (1 sale). No open-market buys.
- Last insider buy: Glen R. Anderson (10% owner), $56K, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (1 sale). Last close $2.99 on Oct 22, 2026.
Recent INDP insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Mar 23, 2026 | David E. Lazar (Director) | Sold | — |
| Mar 23, 2026 | David E. Lazar (Director) | Sold | — |
| Feb 26, 2026 | Jerome D Jabbour (Director) | Bought (not open market) | — |
| Feb 11, 2026 | Jeffrey A Meckler (CEO) | Sold (not open market) | $144K |
| Feb 11, 2026 | Jeffrey A Meckler (CEO) | Sold (not open market) | $101K |
| Feb 11, 2026 | Jeffrey A Meckler (CEO) | Sold (not open market) | $44.7K |
| Feb 11, 2026 | Jeffrey A Meckler (CEO) | Bought (not open market) | $21.2K |
| Feb 11, 2026 | Jeffrey A Meckler (CEO) | Bought (not open market) | $5.3K |
| Feb 11, 2026 | Jeffrey A Meckler (CEO) | Bought (not open market) | $2.7K |
| Jan 20, 2026 | Avraham Ben-Tzvi (Director) | Bought (not open market) | — |
| Jan 7, 2026 | David Natan (Director) | Bought (not open market) | — |
| Dec 23, 2025 | Avraham Ben-Tzvi (Director) | Bought (not open market) | — |
| Dec 22, 2025 | Jeffrey A Meckler (CEO) | Bought (not open market) | $440K |
| Dec 22, 2025 | Walt Addison Linscott (COO) | Bought (not open market) | $110K |
| Dec 22, 2025 | Michael James Newman (C-suite exec) | Bought (not open market) | $106K |
| Dec 22, 2025 | Nir Sassi (CFO) | Bought (not open market) | $54.3K |
Who's trading INDP
- David E. Lazar, Director: sold $0 (2 sales), last Mar 23, 2026
- Jerome D Jabbour, Director: other filings, last Feb 26, 2026
- Jeffrey A Meckler, CEO: other filings, last Feb 11, 2026
- Avraham Ben-Tzvi, Director: other filings, last Jan 20, 2026
- David Natan, Director: other filings, last Jan 7, 2026
- Michael James Newman, C-suite exec: other filings, last Dec 22, 2025
- Nir Sassi, CFO: other filings, last Dec 22, 2025
- Walt Addison Linscott, COO: other filings, last Dec 22, 2025
Get free alerts when an insider at Indaptus Therapeutics, Inc files a new trade →